What Researchers Did
Researchers reviewed human and veterinary literature to understand the mechanisms and clinical applications of hyperbaric oxygen therapy (HBOT).
What They Found
Hyperbaric oxygen therapy (HBOT) is increasingly accepted as an adjunctive treatment for conditions like problem wounds and central nervous system diseases in human medicine. Animal models, including rodents, rabbits, dogs, cats, and pigs, have been used to study HBOT's effects, showing a substantial body of literature on its benefits and adverse effects.
What This Means for Canadian Patients
While currently used for specific conditions, hyperbaric oxygen therapy may become an additional therapeutic option for Canadian patients with select problem wounds, spinal cord injury, or cerebral ischemic injury as technology advances. Patients should discuss with their healthcare providers if HBOT is a suitable adjunctive treatment for their specific medical needs.
Canadian Relevance
This review article does not have a direct Canadian connection.
Study Limitations
As a review, this study synthesizes existing literature rather than presenting new primary research data or specific clinical trial outcomes.